24 In this review, we discuss the benefits and challenges associated with the small-molecule GLP-1 RA drugs from pre-clinical and clinical studies
Sensory nerve damage produces the symptoms most people associate with neuropathy: numbness, tingling, burning pain, pins-and-needles sensations, and hypersensitivity to touch
The landmark STEP 1 extension trial, published in Diabetes, Obesity and Metabolism (2022), followed participants after withdrawal of semaglutide 2.4 mg
Type 2 diabetes itself is associated with sexual dysfunction in both men and women due to vascular changes, neuropathy, and hormonal imbalances
You may be eligible to participate if you are 18 or older and have: Been diagnosed with painful diabetic peripheral neuropathy or report pain that is consistent with a diagnosis and has been going on for at least three months Been diagnosed with type 2 diabetes at least six months prior to screening Been taking any diabetes or pain medications that you are using regularly for at least three months prior to screening An A1C of 6.0-10.5% at screening A BMI greater than 25 Women who are pregnant, breastfeeding, or planning to become pregnant are not eligible to participate
Lidocaine is a numbing agent thats very similar to what a dentist gives you prior to filling a cavity
